Reactivation of ERKs can also occur through enhanced RAF dimerization, a key mechanism of resistance to RAFi in melanoma [32], as well as the abnormal expression of other RAF isoforms, such as CRAF and ARAF [14,33]. The gene discussed is RAF1; the disease is melanoma.